Plant-based biotechnology company BPH Global (ASX: BP8) has reported first-month revenue of approximately $150,000 from its ...

Singular Health Group (ASX: SHG) has signed a binding $2 million contract with US firm Provider Network Solutions (PNS) for ...

Amplia Therapeutics (ASX: ATX) continues to make excellent progress with focal adhesion kinase (FAK) inhibitor narmafotinib, ...

Sprintex (ASX: SIX) has secured a $377,000 order from Türkish distributor Net 0 Enerji for the supply of high-capacity G ...

Fraud-prevention software developer Adveritas (ASX: AV1) has completed an $8.5 million placement to existing shareholders and new institutional investors ...

INOVIQ (ASX: IIQ) has reported superior efficacy from an in vitro study of CAR-exosomes cancer therapy that killed almost 88% ...

Bioxyne (ASX: BXN) has received certificates of Good Manufacturing Practice (GMP) compliance under mutual recognition ...